Product Name: Human SLAMF6 Antibody (SGN-CD352A, Research Use)
Catalog Number: NBR-0437
Target Name: SLAMF6
Trade Name: SGN-CD352A
Antibody Drug Description: SGN-CD352A is an antibody-drug conjugate (ADC) consisting of an engineered cysteine humanized monoclonal antibody (EC-mAb) targeting CD352 (SLAM family member 6; SLAM6) that is conjugated to the cytotoxic, DNA minor-groove crosslinking agent pyrrolobenzodiazepine (PBD) dimer, with potential antineoplastic activity. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: SLAMF6
Synonyms: CD352; KALI; KALIb; Ly108; NTB-A; NTBA; SF2000
Target Description: Self-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family. SLAM receptors triggered by homo-or heterotypic cell-cell interactions are modulating the activation and differentiation of a wide variety of immune cells and thus are involved in the regulation and interconnection of both innate and adaptive immune response.
Ensembl: ENSG00000162739
Uniprot: Q96DU3